Skip to content

Efficiency of non-invasive light source treatment with heated albumin mixed with platelet concentrate called as concentrated growth factors in the treatment of oral bone deficiency

Effect of low level laser therapy and Activated plasma albumin gel in the treatment of intrabony defects using simplified papilla preservation flap a randomized control trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079499
Enrollment
42
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Activated plasma albumin gel in intrabony defects: In intrabony defects placing a activated plasma albumin gel for regeneration of bone Control Intervention1: Concentrated growth factor

Sponsors

DRShanmugaapriyan KR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Intrabony defects with 2 or 3 walls 2)Defect angle less than 40°

Exclusion criteria

Exclusion criteria: 1) Patients requiring antibiotic prophylaxis before the periodontal examination 2) Sites with malocclusion and inadequate proximal contacts 3) Patients under immunosuppressive drugs 4) Patients with systemic disease that contraindicates periodontal surgery 5) Patients who are current smokers and pan chewers 6) Sites with non-accessible furcation involvement 7) Pregnancy

Design outcomes

Primary

MeasureTime frame
To ensure radiographic bone fill after 6monthsTimepoint: To ensure radiographic bone fill after 6months

Secondary

MeasureTime frame
To assess improvement in CAL,BOP and PPDTimepoint: Baseline and 6months

Countries

India

Contacts

Public ContactDr Santhosh Venkadassalapathy

SRM Dental College,Chennai

drsandev@gmail.com8148877084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026